Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems

K-Number: K172162 · 2017-08-16

ApplicantSiemens Healthcare
Decision Date2017-08-16
Product CodeIYN
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems is a medical device manufactured by Siemens Healthcare. It received FDA 510(k) clearance on 2017-08-16 under approval number K172162. The device is classified under product code IYN. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems?

ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems is a medical device that received FDA 510(k) clearance on 2017-08-16. It is manufactured by Siemens Healthcare. The 510(k) number is K172162.

When was ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems approved by the FDA?

ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems received FDA 510(k) clearance on 2017-08-16, under approval number K172162.

What company makes ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems?

ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems is manufactured by Siemens Healthcare.

What is the FDA product code for ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems?

The FDA product code for ACUSON S3000 S2000 S1000 Diagnostic Ultrasound Systems is IYN.

Related Clinical Trials

NCT07040696 Accuracy of Venous Excess Ultrasound Score at Hospital Admission to Predict Acute Kidney Injury COMPLETED NCT05857852 Low-Intensity Focused Ultrasound for Cocaine Use Disorder COMPLETED NCT07385508 Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches RECRUITING NCT07234188 POM vs HFNC for Hypoxemia Prevention in Children COMPLETED NCT04896476 Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae COMPLETED NCT07590063 Technology Development of Diagnostic Ultrasound System for Obstetric Imaging NOT_YET_RECRUITING

Related PubMed Literature

PMID: 42207283 [Legal responsibility in AI-assisted radiological reporting]. Radiologie (Heidelberg, Germany) (2026) PMID: 42037982 Ethical, legal, and social implications of AI-enabled digital therapeutics: A comparative analysis of risk-based regulatory frameworks in the European Union and Japan. Digital health (2026) PMID: 41887630 Capacity building for ethical use of artificial intelligence in health: protocol for a scoping review of training initiatives and gaps in Africa. BMJ open (2026) PMID: 41513582 Medical devices for professional use: What assessment, what funding? Therapie (2026)

Related Devices (Code: IYN)

K162845DC-40/DC-35/DC-45/DC-40S/DC-40 Pro Diagnostic Ultrasound SystemShenzhen Mindray Bio-Medical Electronics Co., Ltd. K162902ARIETTA Prologue Diagnostic Ultrasound system and TransducersHitachi , Ltd. K163138Clarius Ultrasound SystemClarius Mobile Health Corp. K163077LOGIQ E9, LOGIQ E9 XDClear 2.0GE Medical Systems Ultrasound and Primary Care Diagnostics K162583ALOKA LISENDO 880Hitachi , Ltd. K163020Xperius Ultrasound SystemPhilips Health Care

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑